China Shineway Pharmaceutical Group

Sustainability Report and Carbon Intensity Rankings

Is China Shineway Pharmaceutical Group doing their part?

Their DitchCarbon score is 44

China Shineway Pharmaceutical Group has a DitchCarbon Score of 44 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s carbon intensity, suggesting there is significant room for improvement in reducing emissions. A higher score would demonstrate a stronger commitment to lowering carbon intensity and enhancing their environmental performance.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low




Very high

China Shineway Pharmaceutical Group is part of the industrial manufacturing sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low




Very high

The China Shineway Pharmaceutical Group operates in a region with a carbon intensity rating, which reflects the environmental impact of its energy sources. Since China has a certain carbon intensity level, it influences the sustainability profile of the company, potentially affecting its efforts to reduce its carbon footprint.

...this company is doing 2.71% better in emissions than the industry average.

China Shineway Pharmaceutical Group, founded in 2002, is a prominent player in the pharmaceutical industry located in Wanchai, Hong Kong Island. As part of the industrial manufacturing sector, the company specializes in the development and production of pharmaceutical products. China Shineway Pharma is dedicated to leveraging platforms like LinkedIn to enhance its brand presence and foster professional relationships that contribute to its growth and workforce expansion.

emission intelligence's platform recommendations for China Shineway Pharmaceutical Group

China Shineway Pharmaceutical Group should undertake a thorough inventory of all Scope 1 emissions sources to identify and mitigate direct greenhouse gas outputs, potentially reducing their emissions by 15%.

Bad news, China Shineway hasn't committed to SBTi goals yet

China Shineway Pharmaceutical Group has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company has not publicly defined or committed to clear, science-based emissions reduction targets aligned with the latest climate science to limit global warming.
Not participating

The Ultimate Guide to Building Sustainability Into Procurement​

1. Reputation and Brand Image

2. Corporate Social Responsibility

3. Becoming a Customer of Choice

4. Stakeholder Engagement

5. Risk Management

Case study — How Compleat's clients use our carbon data

Making Compleat’s customers climate heroes. Download the 19-page case study PDF.

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Looking for a specific company?

Search our company directory or contact us for custom data requests.